Ignite Creation Date:
2025-12-25 @ 3:43 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT03712202
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-06
First Post:
2018-08-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-23
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-06
First Submit QC Date:
None
Study First Post Date:
2018-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL